Pharmacokinetic characterization of amantadine in human brain tissue
2006 | journal article. A publication with affiliation to the University of Göttingen.
Jump to: Cite & Linked | Documents & Media | Details | Version history
Cite this publication
Pharmacokinetic characterization of amantadine in human brain tissue
Kornhuber, J.; Riederer, P.; Bleich, S.; Wiltfang, J.; Kraus, T. & Meineke, I. (2006)
Therapeutic Drug Monitoring, 28(5) pp. 693-695. DOI: https://doi.org/10.1097/01.ftd.0000245390.48552.04
Documents & Media
Details
- Authors
- Kornhuber, Johannes; Riederer, Peter; Bleich, Stefan; Wiltfang, Jens; Kraus, Thomas; Meineke, Ingolf
- Abstract
- Amantadine concentrations in human brain tissue were assessed in order to estimate population pharmacokinetic parameters using the computer program NONMEM. The elimination constant in brain tissue was determined to be 0.00447 [1/h], resulting in a t(1/2) Of 6.5 days for the mean patient in the population investigated (n = 19). An estimate of 65.5 L was obtained for the apparent volume of distribution. The elimination half-life of amantadine from brain tissue is much longer than from blood and is comparable to the previously investigated neuroleptic drugs haloperidol and levomepromazine.
- Issue Date
- 2006
- Status
- published
- Publisher
- Lippincott Williams & Wilkins
- Journal
- Therapeutic Drug Monitoring
- ISSN
- 0163-4356
